Published in Circ Res on October 29, 2013
Hypoxia fate mapping identifies cycling cardiomyocytes in the adult heart. Nature (2015) 2.58
c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart. PLoS One (2014) 1.20
Challenges in identifying the best source of stem cells for cardiac regeneration therapy. Stem Cell Res Ther (2015) 0.95
Cardiac stem cell niches. Stem Cell Res (2014) 0.91
Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology. Circ Res (2016) 0.91
Making it stick: chasing the optimal stem cells for cardiac regeneration. Expert Rev Cardiovasc Ther (2014) 0.91
Origin of cardiomyocytes in the adult heart. Circ Res (2015) 0.89
Mesenchymal Stromal Cells and Tissue-Specific Progenitor Cells: Their Role in Tissue Homeostasis. Stem Cells Int (2015) 0.84
Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice. Am J Physiol Heart Circ Physiol (2014) 0.84
SCF/c-kit transactivates CXCR4-serine 339 phosphorylation through G protein-coupled receptor kinase 6 and regulates cardiac stem cell migration. Sci Rep (2016) 0.84
Bone Marrow Is a Reservoir for Cardiac Resident Stem Cells. Sci Rep (2016) 0.82
The modulation of cardiac progenitor cell function by hydrogel-dependent Notch1 activation. Biomaterials (2014) 0.82
Characterization of secretomes provides evidence for adipose-derived mesenchymal stromal cells subtypes. Stem Cell Res Ther (2015) 0.80
Cardiac stem cells: biology and clinical applications. Antioxid Redox Signal (2014) 0.80
Matrix metalloproteinase 9 secreted by hypoxia cardiac fibroblasts triggers cardiac stem cell migration in vitro. Stem Cells Int (2015) 0.79
C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways. PLoS One (2015) 0.78
Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiology. World J Stem Cells (2017) 0.78
Cardiac aging - Getting to the stem of the problem. J Mol Cell Cardiol (2015) 0.78
Stem cells and diabetic cardiomyopathy: from pathology to therapy. Heart Fail Rev (2016) 0.77
Redox signaling in cardiac renewal. Antioxid Redox Signal (2014) 0.77
Spatial and temporal expression of c-Kit in the development of the murine submandibular gland. J Mol Histol (2014) 0.76
Pathological Left Ventricular Hypertrophy and Stem Cells: Current Evidence and New Perspectives. Stem Cells Int (2015) 0.76
Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide? Stem Cells Int (2016) 0.76
p53 Modulates the Fate of Cardiac Progenitor Cells Ex Vivo and in the Diabetic Heart In Vivo. EBioMedicine (2017) 0.75
Rejuvenating the senescent heart. Curr Opin Cardiol (2015) 0.75
Natriuretic Peptide Receptor B modulates the proliferation of the cardiac cells expressing the Stem Cell Antigen-1. Sci Rep (2017) 0.75
Physiological and hypoxic oxygen concentration differentially regulates human c-Kit+ cardiac stem cell proliferation and migration. Am J Physiol Heart Circ Physiol (2016) 0.75
Identification of cardiac stem cells within mature cardiac myocytes. Cell Cycle (2015) 0.75
Strategies to Enhance the Effectiveness of Adult Stem Cell Therapy for Ischemic Heart Diseases Affecting the Elderly Patients. Stem Cell Rev (2016) 0.75
Cardiac Cell Senescence and Redox Signaling. Front Cardiovasc Med (2017) 0.75
Increased Hypoxia Inducible Factor in the Muscles of Tumor-Bearing Mice. Am J Physiol Heart Circ Physiol (2017) 0.75
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13
Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet (2012) 9.86
Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med (2007) 8.06
Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76
Coexistence of quiescent and active adult stem cells in mammals. Science (2010) 7.54
Targeting hypoxia in cancer therapy. Nat Rev Cancer (2011) 7.10
The aging of hematopoietic stem cells. Nat Med (1996) 6.67
Mammalian heart renewal by pre-existing cardiomyocytes. Nature (2012) 5.56
The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell (2010) 5.07
Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell (2010) 4.98
Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell (2010) 4.90
Telomeres and aging. Physiol Rev (2008) 4.79
Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A (2006) 4.58
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A (2005) 4.13
Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res (2004) 4.13
Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res (2005) 3.93
Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation (2012) 2.83
Myocyte turnover in the aging human heart. Circ Res (2010) 2.77
Heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol (2009) 2.68
Molecular imaging of hypoxia. J Nucl Med (2008) 2.61
Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci U S A (2009) 2.60
Pulmonary oxygen toxicity: a review. Pharmacol Rev (1971) 2.59
Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell (2013) 2.58
Aging and disease as modifiers of efficacy of cell therapy. Circ Res (2008) 2.51
Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment. Nat Cell Biol (2013) 2.34
Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res (2008) 2.31
Matricellular proteins in cardiac adaptation and disease. Physiol Rev (2012) 2.01
Ageing: balancing regeneration and cancer. Nature (2006) 1.88
The young mouse heart is composed of myocytes heterogeneous in age and function. Circ Res (2007) 1.69
Cripto regulates hematopoietic stem cells as a hypoxic-niche-related factor through cell surface receptor GRP78. Cell Stem Cell (2011) 1.47
Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers. Radiat Res (2007) 1.42
Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells. Circ Res (2012) 1.37
Average remaining lifetimes can increase as human populations age. Nature (2005) 1.20
The future of aging therapies. Cell (2005) 1.13
Immunohistochemical detection of changes in tumor hypoxia. Int J Radiat Oncol Biol Phys (2009) 1.13
Changes in tumor hypoxia measured with a double hypoxic marker technique. Int J Radiat Oncol Biol Phys (2000) 1.12
Quantifying transient hypoxia in human tumor xenografts by flow cytometry. Cancer Res (2004) 1.06
Alterations of coronary blood flow and reserve with aging in Fischer 344 rats. Am J Physiol (1989) 1.02
Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia. Expert Opin Investig Drugs (2000) 1.00
Trimetazidine, administered at the onset of reperfusion, ameliorates myocardial dysfunction and injury by activation of p38 mitogen-activated protein kinase and Akt signaling. J Pharmacol Exp Ther (2010) 0.98
Detecting changes in tumor hypoxia with carbonic anhydrase IX and pimonidazole. Cancer Biol Ther (2007) 0.95
Enumeration of absolute cell counts using immunophenotypic techniques. Curr Protoc Cytom (2001) 0.89
Ageing of murine small intestinal stem cells. Novartis Found Symp (2001) 0.85
The hypoxic epicardial and subepicardial microenvironment. J Cardiovasc Transl Res (2012) 0.81
Effect of nifedipine on coronary capillary geometry in normotensive and hypertensive rats. Hypertension (1994) 0.80
Pharmacokinetic parameters of recombinant mast cell growth factor (rMGF). Lymphokine Cytokine Res (1992) 0.79
The effect of realistic geometry of capillary networks on tissue PO2 in hypertrophied rat heart. Adv Exp Med Biol (1992) 0.77
Hypoxia and visualization of the stem cell niche. Methods Mol Biol (2013) 0.77
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45
Chimerism of the transplanted heart. N Engl J Med (2002) 8.69
Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76
Evidence for human lung stem cells. N Engl J Med (2011) 5.67
Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med (2006) 5.33
Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A (2006) 4.58
Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res (2004) 4.13
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A (2005) 4.13
Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res (2005) 3.93
Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A (2005) 3.93
Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A (2005) 3.64
Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation (2010) 3.42
Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res (2004) 3.39
Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev (2005) 3.30
Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res (2008) 3.07
Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A (2007) 3.06
Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A (2003) 2.95
Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med (2006) 2.92
Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res (2004) 2.91
HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest (2003) 2.89
CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood (2004) 2.84
Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation (2012) 2.83
Cardiomyogenesis in the adult human heart. Circ Res (2010) 2.79
Myocyte turnover in the aging human heart. Circ Res (2010) 2.77
Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res (2011) 2.76
Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A (2006) 2.75
Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res (2006) 2.71
Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci U S A (2009) 2.60